Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and β-cells

Diabetes

Volumn 50, Issue 5, 2001, Pages 1047-1055

  Han, Xiao ^a   Sun, Yujie ^a   Scott, Stephen ^a   Bleich, David ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 0035033889     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.5.1047     Document Type: Article

References (39)

1. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing
2. Distinct populations of keratinocytes express stromelysin-1 and -2 in chronic wounds
3. Direct evidence linking expression of matrix metalloproteinase 9 to the metastatic phenotype in transformed rat embryo cells
4. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
5. High levels of messenger RNAs for tissue inhibitor of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastasis
6. Tumor targeting with a selective gelatinase inhibitor
7. Prolonged activation of jun and collagenase genes by tumor necrosis factor
8. A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development
9. Matrix metalloproteinases regulate morphogenesis, migration, and remodeling of epithelium, tongue, skeletal muscle, and cartilage in the mandibular arch
10. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage
11. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
12. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis
13. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis: A longitudinal clinical and MRI study
14. Cleavage of b-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: Evidence for a role for caspases and metalloproteinases
15. Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase
16. Processing of tumor necrosis factor-α by metalloproteinases
17. Regulation of tumor necrosis factor-α processing by a metalloproteinase inhibitor
18. In vitro suppression of programmned cell death of B cells by tissue inhibitor of metalloproteinases-1
19. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells
20. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans
21. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic β cells
22. The role of interleukin-1 in the pathogenesis of IDDM
23. Is there a role for nitric oxide in β-cell dysfunction and damage in IDDM?
24. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus
25. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse
26. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells
27. The role of Fas in autoimmune diabetes
28. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice
29. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response
30. Interleukin-1β-induced nitric oxide synthase expression by rat pancreatic β-cells: Evidence for the involvement of nuclear factor kB in the signaling mechanism
31. Cytokines activate the nuclear factor κB (NF-κB) and induce nitric oxide production in human pancreatic islets
32. Cytokine induction of NO synthase II in human DLD-1 cells: Roles of the JAK-STAT, AP-1 and NF-kB-signaling pathways
33. Inducible nitric oxide synthase can be induced in the absence of active nuclear factor-κB in rat mesangial cells: Involvement of the Janus kinase 2 signaling pathway
34. Overexpression of Bcl-x(L) in β-cells prevents cell death but impairs mitochondrial signal for insulin secretion
35. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells
36. TGF-β plays a key role in morphogenesis of pancreatic islets of Langerhans by controlling the activity of the matrix metalloproteinase MMP-2
37. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors
38. Matrix metalloproteinase expression in rat pancreatic islets